CD163 and systemic sclerosis: There were no significant differences in serum concentration of sCD163 between SSc patients receiving different therapies or between those with and without arterial hypertension (data not shown), nor any other significant associations between different treatments or the presence of arterial hypertension and sCD163 levels (Table 2).